Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Rev. bras. hematol. hemoter ; 33(3): 179-184, June 2011. ilus, tab
Article in English | LILACS | ID: lil-596318

ABSTRACT

BACKGROUND: Allogeneic hematopoietic stem cell transplantation with HLA-identical donors has been established for the treatment of acute myeloid leukemia patients for over 30 years with a cure rate of 50 percent to 60 percent. OBJECTIVES: To analyze the overall survival of patients and identify factors that influence the outcomes of this type of transplant in patients in 1st complete remission who received a busulfan and melphalan combination as conditioning regimen. METHODS: Twenty-five consecutive patients with acute myeloid leukemia were enrolled between 2003 and 2008. The median age was 34 years old (Range: 16 - 57 years). All patients received cyclosporine and methotrexate for prophylaxis against graft-versus-host disease. Median neutrophil engraftment time was 16 days (Range: 7 - 22 days) and 17 days (Range: 7 - 46 days) for platelets. Sinusoidal obstructive syndrome was observed in three patients, seven had grade II acute graft-versus-host disease and one extensive chronic graft-versus-host disease. RESULTS: The overall survival by the Kaplan-Meier method was 48 percent after 36 months with a plateau at 36 months after transplantation. Intensive consolidation with high-dose arabinoside resulted in an improved survival (p-value = 0.0001), as did grade II acute graft-versus-host disease (p-value = 0.0377) and mild chronic graft-versus-host disease (p-value < 0.0001). Thirteen patients died, five due to infection within 100 days of transplant, two due to hemorrhages, one to infection and graftversus-host disease and three relapses followed by renal failure (one) and infection (two). The cause of death could not be determined for two patients. CONCLUSION: The busulfan and melphalan conditioning regimen is as good as other conditioning regimens providing an excellent survival rate.


Subject(s)
Humans , Adult , Middle Aged , Busulfan/administration & dosage , Cyclophosphamide/administration & dosage , Graft vs Host Disease , Hematopoietic Stem Cell Transplantation , Leukemia, Myeloid, Acute , Melphalan/administration & dosage , Remission Induction , Survival Analysis
2.
J. bras. med ; 70(6): 48-52, jun. 1996. ilus, tab, graf
Article in Portuguese | LILACS | ID: lil-179813

ABSTRACT

Os autores relatam caso de tuberculose de coluna vertebral (mal de Pott) associado a meningoencefalite tuberculose em paciente de 51 anos, sexo masculino, com história crônica de confusao mental e dor em regiao lombar. Ressaltam o valor de tomografia computadorizada (TC), da ressonância nuclear magnética (RNM) e da cintilografia óssea (CO) como métodos diagnósticos auxiliares na avaliaçao do comprometimento do sistema nervoso central e coluna vertebral.


Subject(s)
Humans , Male , Middle Aged , Tuberculosis, Meningeal/complications , Tuberculosis, Spinal/complications , Tuberculosis, Meningeal/diagnosis , Tuberculosis, Meningeal/drug therapy , Tuberculosis, Spinal/diagnosis , Tuberculosis, Spinal/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL